Baxter Cefazolin in Dextrose Injection - safety alert
Official notice
24 Jul 2026
An official FDA notice concerns Cefazolin in Dextrose Injection. The notice reports a potential product safety risk. Follow the official notice for consumer instructions. Published 2026-07-24. Lots: LD175708, Exp. Check the official notice for the complete list.
What to do now
Instructions for consumers are available in the official FDA notice.
Official notice
2026-07-24
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Follow the official notice if they match.
Lots
Checked manually this time?
The app alerts you when a new official recall is published — no searching, no checking back.
Turn on recall alertsAffected products
Affected products
Product 1
Where it was sold
Where it was sold
The source does not list specific retailers. See the official notice for where affected products were sold.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Baxter. Contact: Baxter International Inc.. Phone 1-800-332-1088, (888) 229-0001, (224) 948-5353.
Source & status
Source & status
Recall details
Recall details
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeRelated recalls
Risk not stated by source70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container - safety alert
Brand match
Risk not stated by source
Markets
Risk not stated by sourceCefazolin in Dextrose Injection - safety alert
Brand match
Risk not stated by source
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
a product listed in the official notice - safety alert
Brand match
Critical risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
a product listed in the official notice - safety alert
Brand match
Medium risk
Markets
MediumPapaverine Hydrochloride Injection, USP 60 mg/ 2 mL - safety alert
Brand match
Medium risk
Markets
Mediuma product listed in the official notice - safety alert
Brand match
—
Markets
Risk not stated by source70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container - safety alert
Brand match
Risk not stated by source
Markets
Risk not stated by sourceCefazolin in Dextrose Injection - safety alert
Brand match
Risk not stated by source
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
a product listed in the official notice - safety alert
Brand match
Critical risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
a product listed in the official notice - safety alert
Brand match
Medium risk
Markets
MediumPapaverine Hydrochloride Injection, USP 60 mg/ 2 mL - safety alert
Brand match
Medium risk
Markets
Mediuma product listed in the official notice - safety alert
Brand match
—
Markets
Weekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.
This recall was published 24 Jul 2026. The next one won't wait for you to search.
RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.
